A co-founder and co-leader of the firm’s Psychedelics and Emerging Therapies Practice Group, Natasha advises clients on the regulatory matters inherent in new drug development. She also advises behavioral health clients on compliance matters. Natasha approaches her practice with great passion for the promise of psychedelics and other new drugs….
View more